Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 23;7(10):4330-49.
doi: 10.3390/toxins7104330.

AFM₁ in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination

Affiliations
Review

AFM₁ in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination

Laura Giovati et al. Toxins (Basel). .

Abstract

Aflatoxins (AFs) are toxic, carcinogenic, immunosuppressive secondary metabolites produced by some Aspergillus species which colonize crops, including many dietary staple foods and feed components. AFB₁ is the prevalent and most toxic among AFs. In the liver, it is biotransformed into AFM₁, which is then excreted into the milk of lactating mammals, including dairy animals. AFM₁ has been shown to be cause of both acute and chronic toxicoses. The presence of AFM₁ in milk and dairy products represents a worldwide concern since even small amounts of this metabolite may be of importance as long-term exposure is concerned. Contamination of milk may be mitigated either directly, decreasing the AFM₁ content in contaminated milk, or indirectly, decreasing AFB₁ contamination in the feed of dairy animals. Current strategies for AFM₁ mitigation include good agricultural practices in pre-harvest and post-harvest management of feed crops (including storage) and physical or chemical decontamination of feed and milk. However, no single strategy offers a complete solution to the issue.

Keywords: aflatoxin; biocontrol; biotransformation; enterosorption; milk; vaccination.

PubMed Disclaimer

References

    1. McLean M., Dutton M.F. Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther. 1995;65:163–192. doi: 10.1016/0163-7258(94)00054-7. - DOI - PubMed
    1. Medina A., Rodriguez A., Magan N. Effect of climate change on Aspergillus flavus and aflatoxin B1 production. Front. Microbiol. 2014 doi: 10.3389/fmicb.2014.00348. - DOI - PMC - PubMed
    1. Sudakin D.L. Dietary aflatoxin exposure and chemoprevention of cancer: A clinical review. J. Toxicol. Clin. Toxicol. 2003;41:195–204. doi: 10.1081/CLT-120019137. - DOI - PubMed
    1. Kelly J.D., Eaton D.L., Guengerich F.P., Coulombe R.A., Jr. Aflatoxin B1 activation in human lung. Toxicol. Appl. Pharmacol. 1997;144:88–95. doi: 10.1006/taap.1997.8117. - DOI - PubMed
    1. Jakab G.J., Hmieleski R.R., Zarba A., Hemenway D.R., Groopman J.D. Respiratory aflatoxicosis: Suppression of pulmonary and systemic host defenses in rats and mice. Toxicol. Appl. Pharmacol. 1994;125:198–205. doi: 10.1006/taap.1994.1065. - DOI - PubMed

MeSH terms

LinkOut - more resources